Canada based Biolyse Pharma Seeks to Manufacture COVID-19 Vaccines for Low-Income Countries, may test Canada’s compulsory licensing for export law

On March 11th 2021, Biolyse Pharma (“Biolyse”) issued a statement publicly indicating their capacity to manufacture a COVID-19 vaccine and their intent to apply for a compulsory license in Canada. Biolyse is a Canadian manufacturer of cancer drugs based out… Continue Reading

KEI Comments on NIH License to McSAF for Antibody-Drug Conjugates for Cancer

Knowledge Ecology International (KEI) offered the following comments to the National Institutes of Health (NIH) concerning the “Prospective Grant of an Exclusive Patent License: Antibody-Drug Conjugates (ADCs) for Targeting CD56-Positive Tumors” (89 FR 40495) to McSAF Inside Oncology SAS (McSAF).… Continue Reading

KEI Comments on NIH Exclusive License to INTcRON

On Tuesday June 4, 2024, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding “Prospective Grant of an Exclusive Patent License: T Cell Receptor Fusion Proteins for the Treatment of Cancer” (89 FR 43859) to… Continue Reading

Sanctions for Non Disclosure, as Set Out in Article 6 of the WIPO Basic Proposal on Intellectual Property, Genetic Resources and Traditional Knowledge, Should Include Possible Revocation of a Patent

On May 15, 2024, Knowledge Ecology International published an article on “Sanctions for Non Disclosure, as Set Out in Article 6 of the WIPO Basic Proposal on Intellectual Property, Genetic Resources and Traditional Knowledge, Should Include Possible Revocation of a… Continue Reading

UN rejects amendment to limit technology transfer to “voluntary and mutually agreed terms” in resolution on global health

Revised May 6, 2024 Against the backdrop of the tortuous negotiations among WHO Member States on technology transfer and know-how at the last mile of the pandemic agreement talks, on Wednesday, 1 May 2024, Switzerland offered a surprise amendment in… Continue Reading

Letter to Anne Yu, Director for Global Pandemic Preparedness, NSC, on negotiations for WHO pandemic agreement

This was sent via email today. Jamie ————— May 1, 2024 Anne Yu Director for Global Pandemic Preparedness Development, Global Health and Humanitarian Response, National Security Council Staff, Executive Office of the President Dear Anne Yu, I’m guessing you are… Continue Reading

The WHO Pandemic agreement, language on mutually agreed terms for technology transfer, and claims under investor-state dispute resolution (ISDS)

This is an annex to the document: KEI comments on six references to “mutually agreed terms” in the WHO pandemic agreement negotiating text: A/INB/9/3 Rev.1, 22 April 2024, which is available as a PDF here: KEI.MutuallyAgreedTerms.A_INB_9_3Rev1.22April2024draft Annex on Investor-State Dispute… Continue Reading